This is concordant with the notion that tumor-infiltrating CD8+ T cells exhibit enhanced expression of programmed cell death protein 1 (PDCD1), an immune-inhibitory receptor associated with an “exhausted” CD8+ T-cell phenotype [18]. This evidence concerns the gene CD8A and neoplasm.